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Vascular access failure (VAF) is the most common reason
for hospitalization among hemodialysis (HD) patients. The
economic burden of VAF is estimated to be greater than 1
billion dollars per year and continues to grow. The purpose
of this special issue is to focus on recent advances in our
understanding of dialysis access dysfunction.
Thanks in part to several national initiatives, the rate of
arteriovenous ﬁstula (AVF) placement continues to rise in
the United States. AVF failure remains a major concern. Al-
though the detection of early stenosis with preemptive cor-
rection prior to thrombosis seems to be a plausible option to
prevent access failure, there is much debate, on the basis of of
surveillance studies, as to whether early surveillance actually
improves the longevity of an access system.
Evaluating the available information for surveillance,
speciﬁcally the data for AVF stenosis and survival, is neces-
sary to determine if surveillance is of any beneﬁt. In an
attempt to clarify ambiguities, one of the articles in this issue
attempts to review the question: Does regular surveillance
improve the long-term survival of arteriovenous ﬁstulas?
Similarly, L. Kumbar et al., have contributed to this spe-
cial issue with an evaluation of access surveillance outcomes.
They state that although diﬀerent techniques and methods
are available for identifying access dysfunction, the scientiﬁc
evidence for the optimal methodology is lacking. A small
number of randomized controlled trials have evaluated the
role of diﬀerent surveillance techniques. The authors con-
clude that the limited randomized studies especially involv-
ing ﬁstulae and small sample size of the published studies
with conﬂicting results highlight the need for a larger multi-
centered randomized study with hard clinical end points to
evaluate the optimal surveillance strategy for both ﬁstulas
and grafts.
Another important contribution is made by M. L. Zadeh
et al. in this special issue. The authors observe that while
native AVF is the recommended vascular access for HD, its
failure to mature remains a major problem. The aim of their
studywastodeterminethecorrelationbetweendiameterand
maturation of vessels in radiocephalic AVF. The authors per-
formed a prospective cross-sectional study carried out dur-
ing 2006-2007 on 96 hemodialysis patients from Hashem-
inejad Kidney Center. The maturation of ﬁstula showed cor-
relation with vein diameter, but no correlation was seen with
the diameter of the arteries.
Inﬂammation is a problem for dialysis access as well as
for ESRD patients’ cardiovascular health. The contribution
of the dialysis vascular access type to inﬂammation, however,
remainslargelyundeﬁned.Thisspecialissuecontainsapaper
describing a prospective observational study in an incident
HD population. C-reactive protein (CRP), interleukin-6 (IL-
6), and interferon-γ-induced protein (IP-10) were measured
before and at 6-time points after access placement for 1 year.
Am i x e de ﬀects model was performed to adjust for age, sex,
race, coronary artery disease, diabetes mellitus, infections,
accessthrombosis,initiationofHD,anddaysafteraccesssur-
gery.IncomparisontoAVFs,thepresenceofatunneledcath-
eter (TC) was associated with signiﬁcantly higher levels of
CRP. Patients who initiate HD with a TC or an AVG have a
heightened state of inﬂammation, which may contribute to
the excess 90-day mortality after HD initiation.
These paper and several additional important contri-
butions comprise this special issue on dialysis access. The2 International Journal of Nephrology
guest editors hope that the readership of International Jour-
nal of Nephrology ﬁnds these contributions useful and en-
lightening.
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